BABA
Alibaba Group Holding Limited
BABA has the edge over CCS overall, supported by stronger valuation and stronger modeled upside.
CCS
Century Communities, Inc.
CCS trails on the overall score without a compensating advantage in the available component scores.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
CCS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Under pressure | |
| Stable |
CCS's profitability and balance sheet are currently stable, but its revenue and cash flow are under pressure.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA has the edge over CCS in the historical PE scenario, which offers more potential upside but is not a forecast.
CCS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.2x | $15.75 | -70% |
| Fair | 8x | $29.98 | -42% |
| Expensive | 11x | $39.91 | -23% |
| Current | 14x | $51.92 | — |
| Forward | 27x | $51.92 | — |
Historical ranges are pointers, not guarantees.
CCS's PE is in its expensive range at 14x. Analysts expect earnings to fall, which would put today's price at 27x next year's earnings.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over CCS on the outlook, with more favorable earnings and revenue expectations.
CCS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect CCS's earnings and profitability to decline, with its revenue holding steady.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over CCS on earnings, with more consistent year-over-year improvement.
CCS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.89 | -50% |
| Q3 2026 | $3.75 | -45% |
| Q2 2026 | $4.56 | -44% |
| Q1 2026 | $4.44 | -54% |
| Q4 2025 | $4.86 | -53% |
| Q3 2025 | $6.85 | -32% |
| Q2 2025 | $8.19 | -18% |
| Q1 2025 | $9.66 | +7.2% |
| Q4 2024 | $10.40 | +29% |
CCS's earnings per share have fallen from their peak: $3.75 over the past year, against $18.20 in late 2022.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over CCS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over CCS on profitability, with a higher operating margin.
CCS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $864.5M | -12% |
| Q2 2026 | $927.2M | -7.3% |
| Q1 2026 | $789.7M | -13% |
| Q4 2025 | $1.2B | -3.1% |
| Q3 2025 | $980.3M | -14% |
| Q2 2025 | $1B | -3.7% |
| Q1 2025 | $903.2M | -4.8% |
| Q4 2024 | $1.3B | +5.6% |
CCS's revenue has slid since its 2024 peak: $864M last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.8% | -3 points |
| Q2 2026 | 5.3% | +0.6 points |
| Q1 2026 | 4.2% | -1.6 points |
| Q4 2025 | 3.8% | -6.8 points |
| Q3 2025 | 4.9% | -4.8 points |
| Q2 2025 | 4.7% | -5.9 points |
| Q1 2025 | 5.8% | -3.1 points |
| Q4 2024 | 11% | +0.2 points |
CCS's operating margin was 1.8% last quarter, down 3 points from the same quarter a year ago, near the bottom of its range since 2019.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
CCS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$142.4M | -$121.6M |
| Q2 2026 | -$89.6M | -$72.1M |
| Q1 2026 | -$57.1M | -$17.1M |
| Q4 2025 | $202.6M | -30% |
| Q3 2025 | -$20.8M | +$81.1M |
| Q2 2025 | -$17.6M | +$100.1M |
| Q1 2025 | -$40M | -355% |
| Q4 2024 | $290.6M | +$310.6M |
CCS has the edge over BABA on cash flow, with more consistent year-over-year improvement.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
CCS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -177K shares |
| 1 year | -5.1% | -1.5M shares |
| 3 years | -12% | -3.8M shares |
| 5 years | -17% | -6M shares |
| Available history | -8.7% | -2.7M shares |
CCS has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $11.6M |
| Q2 2026 | $19.6M |
| Q1 2026 | $40M |
| Q4 2025 | $20M |
| Q3 2025 | $20M |
| Q2 2025 | $48M |
| Q1 2025 | $55.6M |
| Q4 2024 | $30.7M |
CCS spent $91M buying back its own shares over the past year, down 41% from the year before.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA has the edge over CCS on leverage, with a lower net debt burden relative to earnings.
CCS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.2x | Moderate |
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | -0.0x | Net Cash |
CCS's net debt is about 2.2 years of its operating earnings (EBITDA), up from less than a year a year ago.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
CCS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.0 | Neutral |
| Stochastic | 12.1 | Oversold |
CCS's weekly RSI is 39 (neutral) and its Stochastic is 12 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
CCS PE vs Consumer Cyclical Sector
| Metric | CCS | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 18x | 23% below |
| PE % | 95 | 47 | 48 pts above |
CCS has the edge over BABA on valuation relative to its sector.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
CCS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.3 | 7.8% below |
| 20 week MA | $62.7 | 17% below |
| 50 week MA | $61.8 | 16% below |
| 100 week MA | $62.7 | 17% below |
| 200 week MA | $70.9 | 27% below |
CCS is in a downtrend: it's below all five of its weekly moving averages, and 27% below its 200-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
CCS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.3 | $47.5 | +74% |
| 2021 | $47.5 | $79.5 | +67% |
| 2022 | $79.5 | $51.4 | -35% |
| 2023 | $51.4 | $91.1 | +77% |
| 2024 | $91.1 | $73.6 | -19% |
| 2025 | $73.6 | $59.0 | -20% |
| 2026 YTD | $59.0 | $51.9 | -12% |
CCS has the edge over BABA on returns for 2026, with the stronger performance.